Therefore, whilst the Vk*MYC model may not be an ideal model to test the efficacy of a CR diet to delay the progression of MGUS to MM, further studies are still required to investigate the efficacy of fasting prior to chemotherapy to sensitise MM cells and improve patient outcomes. The gene discussed is MYC; the disease is Miyoshi myopathy.